142 related articles for article (PubMed ID: 33240649)
1. The rs78378222 prevalence and the copy loss of the protective allele A in the tumor tissue of diffuse large B-cell lymphoma.
Voropaeva EN; Orlov YL; Pospelova TI; Gurageva AA; Voevoda MI; Maksimov VN; Seregina OB; Churkina MI
PeerJ; 2020; 8():e10335. PubMed ID: 33240649
[TBL] [Abstract][Full Text] [Related]
2. Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma.
Voropaeva EN; Pospelova TI; Voevoda MI; Maksimov VN; Orlov YL; Seregina OB
BMC Med Genomics; 2019 Mar; 12(Suppl 2):35. PubMed ID: 30871527
[TBL] [Abstract][Full Text] [Related]
3. Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222.
Enciso-Mora V; Hosking FJ; Di Stefano AL; Zelenika D; Shete S; Broderick P; Idbaih A; Delattre JY; Hoang-Xuan K; Marie Y; Labussière M; Alentorn A; Ciccarino P; Rossetto M; Armstrong G; Liu Y; Gousias K; Schramm J; Lau C; Hepworth SJ; Schoemaker M; Strauch K; Müller-Nurasyid M; Schreiber S; Franke A; Moebus S; Eisele L; Swerdlow A; Simon M; Bondy M; Lathrop M; Sanson M; Houlston RS
Br J Cancer; 2013 May; 108(10):2178-85. PubMed ID: 23571737
[TBL] [Abstract][Full Text] [Related]
4. A novel TP53 variant (rs78378222 A > C) in the polyadenylation signal is associated with increased cancer susceptibility: evidence from a meta-analysis.
Wang Y; Wu XS; He J; Ma T; Lei W; Shen ZY
Oncotarget; 2016 May; 7(22):32854-65. PubMed ID: 27147571
[TBL] [Abstract][Full Text] [Related]
5. Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome.
Macedo GS; Araujo Vieira I; Brandalize AP; Giacomazzi J; Inez Palmero E; Volc S; Rodrigues Paixão-Côrtes V; Caleffi M; Silva Alves M; Achatz MI; Hainaut P; Ashton-Prolla P
Cancer Genet; 2016 Mar; 209(3):97-106. PubMed ID: 26823150
[TBL] [Abstract][Full Text] [Related]
6. Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data.
Wang Z; Rajaraman P; Melin BS; Chung CC; Zhang W; McKean-Cowdin R; Michaud D; Yeager M; Ahlbom A; Albanes D; Andersson U; Freeman LE; Buring JE; Butler MA; Carreón T; Feychting M; Gapstur SM; Gaziano JM; Giles GG; Hallmans G; Henriksson R; Hoffman-Bolton J; Inskip PD; Kitahara CM; Marchand LL; Linet MS; Li S; Peters U; Purdue MP; Rothman N; Ruder AM; Sesso HD; Severi G; Stampfer M; Stevens VL; Visvanathan K; Wang SS; White E; Zeleniuch-Jacquotte A; Hoover R; Fraumeni JF; Chatterjee N; Hartge P; Chanock SJ
Hum Mutat; 2015 Jul; 36(7):684-8. PubMed ID: 25907361
[TBL] [Abstract][Full Text] [Related]
7. [Frequency, spectrum, and functional significance of TP53 mutations in patients with diffuse large B-cell lymphoma].
Voropaeva EN; Pospelova TI; Voevoda MI; Maksimov VN
Mol Biol (Mosk); 2017; 51(1):64-72. PubMed ID: 28251968
[TBL] [Abstract][Full Text] [Related]
8. rs78378222 polymorphism in the 3'-untranslated region of TP53 contributes to development of age-associated cataracts by modifying microRNA-125b-induced apoptosis of lens epithelial cells.
Zhao Y; Li X; Zhu S
Mol Med Rep; 2016 Sep; 14(3):2305-10. PubMed ID: 27431420
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Li Y; Gordon MW; Xu-Monette ZY; Visco C; Tzankov A; Zou D; Qiu L; Montes-Moreno S; Dybkaer K; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huang Q; Ai W; Ponzoni M; Ferreri AJ; Winter JN; Go RS; Piris MA; Møller MB; Wu L; Wang M; Ramos KS; Medeiros LJ; Young KH
Blood; 2013 May; 121(22):4529-40. PubMed ID: 23515929
[TBL] [Abstract][Full Text] [Related]
10. Rare variants in TP53 and susceptibility to neuroblastoma.
Diskin SJ; Capasso M; Diamond M; Oldridge DA; Conkrite K; Bosse KR; Russell MR; Iolascon A; Hakonarson H; Devoto M; Maris JM
J Natl Cancer Inst; 2014 Apr; 106(4):dju047. PubMed ID: 24634504
[TBL] [Abstract][Full Text] [Related]
11. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
[TBL] [Abstract][Full Text] [Related]
12. Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas.
Zlamalikova L; Moulis M; Ravcukova B; Liskova K; Malcikova J; Salek D; Jarkovsky J; Svitakova M; Hrabalkova R; Smarda J; Smardova J
Oncol Rep; 2017 Oct; 38(4):2535-2542. PubMed ID: 28791403
[TBL] [Abstract][Full Text] [Related]
13. Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors.
Cao Y; Zhu T; Zhang P; Xiao M; Yi S; Yang Y; Li Q; Ling S; Wang Y; Gao L; Zhu L; Wang J; Wang N; Huang L; Zhang P; Zhai Q; Qiu L; Zhou J
Oncotarget; 2016 Dec; 7(50):83294-83307. PubMed ID: 27825110
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup.
Jiang S; Qin Y; Jiang H; Liu B; Shi J; Meng F; Liu P; Yang J; Yang S; He X; Zhou S; Gui L; Liu H; Lin J; Han-Zhang H; Shi Y
Int J Cancer; 2020 Nov; 147(9):2611-2620. PubMed ID: 32399964
[TBL] [Abstract][Full Text] [Related]
15. Exploring the frequency of a TP53 polyadenylation signal variant in tumor DNA from patients diagnosed with lung adenocarcinomas, sarcomas and uterine leiomyomas.
Vieira IA; Viola GD; Pezzi EH; Kowalski TW; Fernandes BV; Andreis TF; Bom N; Sonnenstrahl G; Rocha YMA; Corrêa BDS; Donatti LM; Sant'Anna GDS; Corleta HVE; Brum IS; Rosset C; Vianna FSL; Macedo GS; Palmero EI; Ashton-Prolla P
Genet Mol Biol; 2024; 46(3 Suppl 1):e20230133. PubMed ID: 38252059
[TBL] [Abstract][Full Text] [Related]
16. High-resolution copy number analysis of paired normal-tumor samples from diffuse large B cell lymphoma.
Sebastián E; Alcoceba M; Martín-García D; Blanco Ó; Sanchez-Barba M; Balanzategui A; Marín L; Montes-Moreno S; González-Barca E; Pardal E; Jiménez C; García-Álvarez M; Clot G; Carracedo Á; Gutiérrez NC; Sarasquete ME; Chillón C; Corral R; Prieto-Conde MI; Caballero MD; Salaverria I; García-Sanz R; González M
Ann Hematol; 2016 Jan; 95(2):253-62. PubMed ID: 26573278
[TBL] [Abstract][Full Text] [Related]
17. Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma.
Bernatsky S; Velásquez García HA; Spinelli JJ; Gaffney P; Smedby KE; Ramsey-Goldman R; Wang SS; Adami HO; Albanes D; Angelucci E; Ansell SM; Asmann YW; Becker N; Benavente Y; Berndt SI; Bertrand KA; Birmann BM; Boeing H; Boffetta P; Bracci PM; Brennan P; Brooks-Wilson AR; Cerhan JR; Chanock SJ; Clavel J; Conde L; Cotenbader KH; Cox DG; Cozen W; Crouch S; De Roos AJ; de Sanjose S; Di Lollo S; Diver WR; Dogan A; Foretova L; Ghesquières H; Giles GG; Glimelius B; Habermann TM; Haioun C; Hartge P; Hjalgrim H; Holford TR; Holly EA; Jackson RD; Kaaks R; Kane E; Kelly RS; Klein RJ; Kraft P; Kricker A; Lan Q; Lawrence C; Liebow M; Lightfoot T; Link BK; Maynadie M; McKay J; Melbye M; Molina TJ; Monnereau A; Morton LM; Nieters A; North KE; Novak AJ; Offit K; Purdue MP; Rais M; Riby J; Roman E; Rothman N; Salles G; Severi G; Severson RK; Skibola CF; Slager SL; Smith A; Smith MT; Southey MC; Staines A; Teras LR; Thompson CA; Tilly H; Tinker LF; Tjonneland A; Turner J; Vajdic CM; Vermeulen RCH; Vijai J; Vineis P; Virtamo J; Wang Z; Weinstein S; Witzig TE; Zelenetz A; Zeleniuch-Jacquotte A; Zhang Y; Zheng T; Zucca M; Clarke AE
Lupus Sci Med; 2017; 4(1):e000187. PubMed ID: 29214033
[TBL] [Abstract][Full Text] [Related]
18. Whole-exome and transcriptome sequencing of refractory diffuse large B-cell lymphoma.
Park HY; Lee SB; Yoo HY; Kim SJ; Kim WS; Kim JI; Ko YH
Oncotarget; 2016 Dec; 7(52):86433-86445. PubMed ID: 27835906
[TBL] [Abstract][Full Text] [Related]
19. Characterization of genomic imbalances in diffuse large B-cell lymphoma by detailed SNP-chip analysis.
Scholtysik R; Kreuz M; Hummel M; Rosolowski M; Szczepanowski M; Klapper W; Loeffler M; Trümper L; Siebert R; Küppers R;
Int J Cancer; 2015 Mar; 136(5):1033-42. PubMed ID: 25042405
[TBL] [Abstract][Full Text] [Related]
20. Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma.
Tong Y; Xiang Y; Li B; Bao S; Zhou Y; Yuan W; Ling Y; Hao D; Zhu H; Sun Z
Med Sci Monit; 2018 Oct; 24():7015-7022. PubMed ID: 30279407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
